← Browse by Condition
Medical Condition
pelvic pain
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 3
Pain clinical trials span acute procedural pain, chronic musculoskeletal pain, neuropathic pain, and cancer-related pain β€” each requiring distinct trial designs and patient-reported outcome instruments. The regulatory demand for non-opioid alternatives has intensified the search for novel analgesic mechanisms, particularly ion channel targets and neurostimulation approaches.
Active trials evaluate Nav1.7/1.8 blockers, CGRP antagonists for new indications, spinal cord stimulation refinements, virtual reality-based pain management, and patient-specific ketamine infusion protocols. Pain trials increasingly use ecological momentary assessment (EMA) diary approaches over traditional recall-based pain rating scales.
Frequently Asked Questions — pelvic pain Clinical Trials
How many clinical trials are currently recruiting for pelvic pain?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for pelvic pain, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pelvic pain?
pelvic pain research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pelvic pain clinical trial?
Eligibility criteria for pelvic pain trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06982989
Recruiting
Clinical Study on the Treatment of Pelvic Pain With Wearable Dual-band LED Device
Enrollment
250 pts
Location
China
Sponsor
Peking University Third Hospit...
NCT06487754
Recruiting
New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Enrollment
15 pts
Location
France
Sponsor
University Hospital, Grenoble
NCT06101303
Recruiting
Endometriosis Pain
Enrollment
120 pts
Location
United States
Sponsor
Washington University School o...
NCT06168058
Recruiting
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
Enrollment
40 pts
Location
United States
Sponsor
Weill Medical College of Corne...
NCT06921174 Phase 2
Recruiting
Comparison of the Effectiveness of Classical Perineal Massage Therapy Versus the Use of an Intravaginal Device to Reduce Postpartum Perineal Pain
Enrollment
140 pts
Location
Spain
Sponsor
Instituto Sexológico Murciano
NCT07100782 Phase 3
Recruiting
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
Enrollment
130 pts
Location
United States
Sponsor
University of Michigan
NCT07243587
Recruiting
Cohort of the Franco-European Multidisciplinary Institute of Endometriosis
Enrollment
15,000 pts
Location
France
Sponsor
Clinique Tivoli Ducos
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology